Keto as Adjunctive Therapy in Glioblastoma: Evidence Review

The ketogenic diet has drawn scientific interest as a potential adjunctive therapy for glioblastoma. This aggressive brain cancer presents unique metabolic characteristics that may respond to nutritional ketosis. While not a treatment, the diet’s ability to alter energy metabolism warrants careful examination alongside standard care.

The Metabolic Rationale

Glioblastoma cells rely heavily on glucose for energy through aerobic glycolysis. Ketogenic diets induce nutritional ketosis, reducing glucose availability while providing ketone bodies as an alternative fuel source. Some preclinical studies suggest tumour cells may be less efficient at utilising ketones compared to healthy neurons. This metabolic discrepancy forms the theoretical basis for investigation.

Research indicates ketone metabolism produces fewer reactive oxygen species than glycolysis, potentially creating a less favourable environment for cancer cell proliferation. A 2013 review in the European Journal of Clinical Nutrition noted ketogenic diets’ potential beyond weight loss, including neurological applications.

Clinical Evidence Overview

Human trials remain limited but promising. The ketogenic diet’s safety profile in oncology settings appears reasonable when monitored by specialists. Some case reports describe improved quality of life markers and slower progression when combining keto with standard glioblastoma protocols. However, large randomised controlled trials are still needed.

the keto adaptation timeline varies between individuals, which complicates clinical application. Patients typically require 2-4 weeks to achieve stable ketosis, a significant consideration in aggressive cancers where time matters.

What This Means in Practice

Implementing keto alongside glioblastoma treatment requires specialist supervision. The diet demands careful macronutrient tracking – typically 70-80% fat, 15-20% protein and 5-10% carbs. Tesco sells keto staples like extra virgin olive oil (£5 for 500ml) and tinned sardines (£1.20 per tin) that fit these ratios.

Patients often face practical challenges including treatment side effects that impact appetite. UK oncology dietitians may recommend modified approaches like the Modified Atkins Diet, which allows slightly more protein and carbs while maintaining ketosis.

Safety and Monitoring Considerations

Close medical supervision is essential. Potential interactions exist between keto and certain treatments like corticosteroids, which can raise blood glucose. Regular monitoring of blood ketones, glucose and electrolytes becomes crucial. The diet isn’t appropriate for all patients, particularly those with specific metabolic disorders or advanced cachexia.

common keto electrolyte mistakes become more consequential in medically vulnerable populations. Sodium, potassium and magnesium levels require particular attention when combining keto with cancer therapies.

Frequently Asked Questions

Can keto cure glioblastoma?

No. Current evidence only supports investigation of ketogenic diets as a potential adjunct to standard treatments. There is no nutritional intervention that can cure cancer.

How quickly might someone see effects?

Metabolic changes occur within days, but observable clinical effects would take weeks to months if present. Any dietary approach should complement rather than delay evidence-based treatments.

Is keto safe during chemotherapy?

This requires individual assessment by the oncology team. Some patients tolerate it well, while others may need modifications based on treatment side effects and nutritional status.

The Bottom Line

The ketogenic diet presents an intriguing metabolic approach to glioblastoma support, though current evidence remains preliminary. Its potential lies in altering the tumour microenvironment rather than direct anti-cancer effects. Patients considering this approach should do so under specialist supervision alongside standard care. If you’d rather not do the macro maths yourself, the Keto Dieting app does it for you on Google Play and the App Store.

Educational only — not medical advice. This article is for general information. Speak to your GP before changing your diet, especially if you have type 1 or type 2 diabetes, kidney or liver disease, are pregnant or breastfeeding, or take medication for blood pressure, cholesterol, or blood glucose.

References

Paoli A, Rubini A, Volek JS, Grimaldi KA (2013). Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. European Journal of Clinical Nutrition. https://doi.org/10.1038/ejcn.2013.116
Bueno NB, de Melo IS, de Oliveira SL, da Rocha Ataide T (2013). Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. British Journal of Nutrition. https://doi.org/10.1017/S0007114513000548